A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years - Concepedia

Concepedia

Publication | Open Access

A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years

DOI Full Paper Access

51

Citations

20

References

2019

Year

Nicholas Kitchin, Shon Remich, James T. Peterson, Yahong Peng, William C. Gruber, Kathrin U. Jansen, Michael W. Pride, Annaliesa S. Anderson, Charles Knirsch, Chris Webber

Clinical Infectious Diseases

Abstract

NCT02561195.

References

	Year	Citations

Page 1